Wednesday, December 9, 2020

New compound related to psychedelic ibogaine could treat addiction, depression

A non-hallucinogenic version of the psychedelic drug ibogaine, with potential for treating addiction, depression and other psychiatric disorders, has been developed by researchers.

from Top Health News -- ScienceDaily https://ift.tt/3gxFrI4

No comments:

Post a Comment

Stanford scientists regrow lost cartilage and reverse arthritis in major breakthrough

A new treatment that blocks an aging-related protein restored lost cartilage in old mice and helped prevent arthritis after knee injuries. H...